Company profile
Parallel Industries Inc.
OTC: EAPH · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONCIK 0001071272Reports USD
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ filing timeliness, market scale
Methodology →Revenue TTM
-$351.0k
Rev growth YoY (TTM)
-135.3%
Net income (FY)
—
Employees
6
as of 2026-08-29
Market cap
$26.9k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Parallel Industries Inc.’s financial profile?
Parallel Industries Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
IMV Inc.——Ocean Biomedical, Inc.——MabCure Inc.——Itoco Inc.——Regenicin, Inc.——CERo Therapeutics Holdings, Inc.——Key facts
CEOEvan Karras
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: EAPH
Employees6
IPO date1999-09-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.